GSK pulls_out_of COVID collaboration with VIR—(except continuing to support sotrovimab, where approved): https://www.globenewswire.com/news-release/2023/02/13/2607159/0/en/Vir-Biotechnology-Announces-Amended-Collaboration-Agreement-with-GSK.html The collaboration dates to Apr 2020.